Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

122 results about "Tumor resection" patented technology

A tumor resection is surgery for removing a tumor from the body. A resection is defined as a removal of all or part of an organ or bone, so a tumor resection is removal of all or part of a tumor. There are many types of resections and many types of tumor surgery, because each cancer is different and requires a different approach.

Tumor electric field treatment device and treatment system

The utility model discloses a tumor electric field treatment device and a treatment system, the tumor electric field treatment device is provided with a frame body and a pole piece module, the frame body forms a skeleton structure of the treatment device, the pole piece module is attached to the frame body, the pole piece module is provided with a plurality of electrode contacts, and each electrode contact can form an active contact or a passive contact. The active contact and the radio frequency generation module can form a loop; after the treatment device is implanted into a tumor excision part, all the electrode contacts form active contacts, and all the electrode contacts and the radio frequency generation module form a loop to distinguish normal tissues from pathological tissues; after the normal tissue and the lesion tissue are distinguished, the electrode contacts in the normal tissue area form passive contacts, and the electrode contacts in the lesion tissue area form active contacts, so that targeted treatment of the lesion tissue is realized, and side effects generated by electric field treatment are reduced.
Owner:WUHAN NEURACOM TECH DEV CO LTD

Digital guide plate for oral cavity tumor excision and contemporaneous bone implantation and preparation method thereof

The invention discloses a digital guide plate for oral cavity tumor excision and contemporaneous bone implantation and a preparation method, the digital guide plate comprises a tumor excision indication guide plate, an autogenous bone osteotomy indication guide plate, an implantation indication guide plate, an implantation reduction guide plate and an autogenous bone reduction guide plate, and the preparation method comprises the following steps: constructing a virtual model and determining a tumor excision range; oral implantation planning is conducted, the position and range of a reconstructed titanium plate are determined, a digital guide plate is printed in a 3D mode, and a temporary abutment is connected to an implantation reduction guide plate through model operation training. By applying the digital guide plate, tumor resection, autogenous bone resection, autogenous bone reduction and precise implant implantation can be achieved in the same operation process. The digitized guide plate is used for guiding the implant to be implanted, the position of the implant is used as a reference, autogenous bone reduction can be accurately guided, and the precision of implant repair can be remarkably improved. The technical problems that in the prior art, the implant position is judged according to experience of doctors, and the autogenous bone reduction precision is not ideal can be solved.
Owner:SICHUAN UNIV

Tumor electric field treatment device, treatment system and manufacturing method of treatment device

The invention discloses a tumor electric field treatment device and system, the tumor electric field treatment device is provided with a frame body and a pole piece module, the frame body forms a skeleton structure of the treatment device, the pole piece module is attached to the frame body, the pole piece module is provided with a plurality of electrode contacts, and each electrode contact can form an active electric contact or a passive electric contact. The active electric contact and the radio frequency generation module can form a loop; after the treatment device is implanted into a tumor excision part, all the electrode contacts form active electric contacts, and all the electrode contacts and the radio frequency generation module form a loop to distinguish normal tissues from pathological tissues; after the normal tissue and the lesion tissue are distinguished, the electrode contacts in the normal tissue area form passive electric contacts, and the electrode contacts in the lesion tissue area form active electric contacts, so that targeted treatment of the lesion tissue is realized, and side effects generated by electric field treatment are reduced.
Owner:WUHAN NEURACOM TECH DEV CO LTD

Double-targeting near-infrared fluorescent probe for estrogen receptor alpha and fibroblast activating protein as well as preparation method and medical application of double-targeting near-infrared fluorescent probe

The invention relates to an estrogen receptor alpha and fibroblast activating protein dual-targeting near-infrared fluorescent probe as well as a preparation method and medical application thereof. Specifically, the probe can be used as a fluorescence probe for developing cells co-expressing the estrogen receptor alpha and the fibroblast activating protein, and can also be used as a near-infrared fluorescence imaging probe for diagnosing benign / malignant lesions such as nodules / tumors co-expressing the estrogen receptor alpha and the fibroblast activating protein. The fluorescent probe can also be applied to research on related biological events in cells for co-expressing the estrogen receptor alpha and the fibroblast activating protein, and particularly can be applied to fluorescent navigation in tumor resection operations for co-expressing the estrogen receptor alpha and the fibroblast activating protein; particularly, the composition can be applied to the synergistic treatment of an anti-estrogen therapy and a photodynamic therapy on a diseased region which co-expresses the estrogen receptor alpha and the fibroblast activating protein.
Owner:NANJING MEDICAL UNIV

A near-infrared second-zone small molecule optical diagnostic and therapeutic reagent based on hydrogen sulfide activation, and its preparation method and application

The present invention provides a hydrogen sulfide-activated near-infrared II small molecule optical diagnostic and therapeutic agent, whose chemical structure is: [Illegible text - likely a missing link]. This diagnostic and therapeutic agent can accurately identify solid tumors overexpressing hydrogen sulfide, effectively distinguishing tumors from normal tissue, and can be used for tumor resection under the guidance of NIR-II fluorescence imaging. Furthermore, it has excellent photothermal conversion efficiency and can successfully ablate tumors under laser irradiation. This agent demonstrates significant advantages in tumor identification and treatment and is expected to become a highly effective molecular tool for tumor diagnosis and treatment.
Owner:THE SECOND PEOPLES HOSPITAL OF SHANDONG PROVINCE (SHANDONG PROVINCIAL EAR NOSE & THROAT HOSPITAL SHANDONG PROVINCIAL INST OF EAR NOSE & THROAT)

A surgical channel for nose-orbital joint approach

The present invention discloses a surgical channel for a nose-orbital joint approach, comprising: a channel main frame, which is worn and installed at the nose-orbital position, and the channel main frame is in an inverted eye-shaped structure; the present invention relates to the field of medical device technology. The surgical channel for the nose-orbital joint approach can fix structures such as endoscope guidance and lighting in the combined nasal endoscope and transorbital approach orbital apex tumor resection surgery by setting a slideway and a corresponding fixing structure, providing the surgeon with a clear and stable surgical field of view, avoiding the tumor from being blocked by tissues such as orbital fat and extraocular muscles; and does not require an assistant to hold tools for assistance, does not rely on the assistant's experience and surgical skills, and is stable and reliable; can effectively avoid damage to important intraorbital structures such as the optic nerve, and increases the safety and efficiency of the surgery; at the same time, ophthalmic surgery can be performed on both sides of the inverted eye-shaped channel main frame, and nasal surgery can be performed in the middle, which can provide a dual-camera synchronous field of view, making the surgical cooperation between nasal and ophthalmic departments more efficient and safe.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

Doxorubicin-loaded anti-tumor hemostatic microspheres and preparation and use thereof

The present application relates to providing a doxorubicin-loaded anti-tumor hemostatic microsphere constructed by a simple, safe and low-cost method and its preparation and application, the doxorubicin-loaded anti-tumor hemostatic microsphere comprises alginate, hemostatic component A, doxorubicin or doxorubicin liposome, crosslinking agent, the hemostatic component A is selected from one or more of carboxymethyl chitosan, hyaluronic acid, collagen, silk fibroin, solve the practical pain point problems such as easy bleeding in tumor resection surgery, large toxicity of chemotherapeutic drugs, large drug dose, frequent drug administration, etc., realize rapid hemostasis in operation, postoperative precise targeted drug delivery, reduce toxic side effects, long-acting drug sustained release, at the same time, all components of the system are safe and reliable, and have good biocompatibility.
Owner:ZHEJIANG SCI-TECH UNIV

Fibroblast cell activating protein inhibitor-chlorine-containing indole heptamethine cyanine dye coupled near-infrared fluorescent probe, preparation method and medical application thereof

The invention relates to a compound as shown in a formula (I) and / or a formula (II) and / or a formula (III) or a tautomer or pharmaceutically acceptable salt thereof, a preparation method and application of the compound or the tautomer or the pharmaceutically acceptable salt in medicine. Specifically, the fluorescent probe can be used as a fluorescent probe for cytological imaging, can also be used as a near-infrared fluorescent imaging probe for diagnosing benign / malignant lesions such as fibrosis, nodules and tumors, and can also be applied to research of related biological events in cytobiology and molecular biology. The fluorescent probe can be particularly applied to fluorescent navigation in tumor resection surgery.
Owner:SUZHOU YUANJU PHARMACEUTICAL TECHNOLOGY CO LTD

Method for providing information for predicting likelihood of bladder cancer recurrence

PCT designated stageWO2026034651A1Biological testingCytologyUrothelial carcinoma
The present invention relates to a method for providing information for predicting the likelihood of bladder cancer recurrence, which provides information that patients who have undergone transurethral resection of a bladder tumor and test positive for suspicious high-grade urothelial carcinoma (SHGUC) or high-grade urothelial carcinoma (HGUC) in a urine cytology test have a higher likelihood of bladder cancer recurrence compared with patients who do not test positive.
Owner:GYEONGSANG NAT UNIV HOSPITAL

Auxiliary operating bed for tumor resection

The invention discloses an auxiliary operating bed for tumor resection, and relates to the technical field of operating beds, the auxiliary operating bed comprises a bed body, sliding rails are fixedly connected to the two sides of the bed body, a moving frame is slidably connected between the sliding rails, a through groove is formed in the moving frame, a communicating groove is formed in one side of the moving frame, the through groove communicates with the communicating groove, and a liquid spraying pipe penetrates through the moving frame; the lower end of the liquid spraying pipe is fixedly connected with a spraying head, and the liquid spraying pipe is communicated with the spraying head, so that the disinfectant can uniformly cover each corner and surface of the operating bed, the bed body can be comprehensively disinfected without dead angles, microorganisms such as bacteria and viruses on the operating bed can be killed, and the infection risk in the operation process is effectively reduced; and an automatic spraying mode is adopted, the disinfection process can be simplified, the skill requirement and the workload of medical staff are reduced, meanwhile, the situation that repeated disinfection is needed due to incomplete disinfection can be reduced through the uniform spraying effect, and therefore the turnover efficiency of the operating room is improved.
Owner:HENAN GONGJIN MEDICAL EQUIPMENT CO LTD

Spherical stent for high posterior mediastinal neurogenic tumor resection

PendingCN119454251Areduce the risk of injuryImprove postoperative quality of lifeDiagnosticsSurgeryHorner syndromePeripheral neuron
The spherical stent comprises a navigation frame, a stent body and a water injection body, the stent body is arranged in the navigation frame, the water injection body is arranged in the stent body, and the water injection body reaches the front inner side of a tumor through the navigation frame and the stent body. The water injection body expands by adding water to the front inner side of the tumor so that the tumor naturally expands. According to the method, the risk of nerve injury is reduced, and for high-position posterior mediastinal neurogenic tumor resection, a traditional operation method has the probability of damaging sympathetic chains or miscarriage, laryngeal recurrence and other nerves of 90% or above, and serious affected side Horner syndromes are caused. According to the spherical stent, a gap is separated from the front inner side of a tumor, a water bag is placed in the gap, water is flushed to expand, so that the tumor naturally expands, energy equipment such as an electrotome, an ultrasonic knife and a bipolar device is not used in the whole process, the risk of injury to peripheral nerves is greatly reduced, the occurrence rate of the postoperative Horner syndrome is reduced to about 15% from 75%-90% in the prior art, and the occurrence rate of the postoperative Horner syndrome is greatly reduced. And better postoperative life quality is brought to patients.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL

Hepatobiliary tumor resection anesthesia depth management method based on multi-modal monitoring

PendingCN121943211ADrug and medicationsSensorsHepatobiliary TumorsBlood flow
The invention discloses a hepatobiliary tumor resection anesthesia depth management method based on multi-modal monitoring, and relates to the technical field of anesthesia control, and the method comprises the following steps: constructing a multi-source energy sensing zone in the whole operation process of hepatobiliary tumor resection, the electromagnetic radiation track, the sudden change moment of the electroencephalogram signal and the micro-amplitude change of the blood flow signal corresponding to the electrotome starting and stopping process are synchronously collected, and an energy disturbance mapping draft is generated based on the collection result. According to the method, through multi-source energy perception and artifact recognition, precise separation of anesthesia signals and awakening signal reconstruction under electrotome interference are achieved, and the accuracy and continuity of anesthesia depth evaluation are improved; a dynamic traction closed loop of electroencephalogram, blood flow and respiration is established through a self-adaptive slow release mechanism of a delayed release window, so that the anesthesia depth is recovered in a self-steady state, and safety and awakening quality in an operation are guaranteed.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Compositions and methods for cancer treatment

To provide localized delivery of immunotherapeutic agents to avoid certain adverse events that can be associated with systemic administration of immunotherapeutic agents.SOLUTION: The present invention provides a method comprising the step of: intraoperative administration, at a tumor resection site of a subject suffering from cancer, of a composition comprising a biomaterial and an inhibitor of a proinflammatory immune response mediated by a p38 mitogen-activated protein kinase (MAPK) pathway.SELECTED DRAWING: None
Owner:DANA FARBER CANCER INSTITUTE INC

Operation channel for nasal-orbital joint path

The invention discloses an operation channel for a nasal-orbital joint path, and the operation channel comprises a channel main frame which is worn and installed at a nasal-orbital position, and the channel main frame is of an inverted-Chinese-character-mu-shaped structure; the invention relates to the technical field of medical instruments. According to the operation channel for the nasal-orbital combined path, by arranging the sliding way and the corresponding fixing structure, an endoscope guiding structure, an illumination structure and the like can be fixed in a nasal-endoscope combined orbital path orbital tip tumor resection operation, a clear and stable operation view is provided for an operator, and the situation that tissues such as orbital fat and extraocular muscles shield tumors is avoided; an assistant does not need to hold a tool for assistance, does not depend on experience of the assistant and surgical techniques, and is stable and reliable; the injury of important intra-orbital structures such as optic nerves can be effectively avoided, and the operation safety and the operation efficiency are improved; meanwhile, ophthalmologic operations can be carried out on the two sides of the channel main frame shaped like the Chinese character'mu ', nasal operations can be carried out in the middle of the channel main frame, double-camera-position synchronous visual fields can be provided, and cooperation of the nasal operations and the ophthalmologic operations is more efficient and safer.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

Medical implants for marking surgical sites

Implantable fiducial marker devices with a predefined shape can deform when stress is applied in vivo, and recover their shape when stress is removed reduce patient discomfort and palpability. The devices can be used to mold irregular tumor resection cavities into a more ideal shape for radiation therapy allowing more accurate treatment. After treatment, the devices resorb eliminating unnecessary testing that occurs when clinicians are unaware of implanted fiducial marker devices. Tissue ingrowth into the devices can also result in improved cosmetic outcomes when the devices are implanted in the breast after a lumpectomy. The devices preferably comprise poly-4-hydroxybutyrate or poly(butylene succinate) or copolymers thereof.
Owner:TEPHA INC

A biomarker for diagnosing pancreatic malignant tumor, a kit and application thereof

PendingCN122283130AAntigenDisease
This invention relates to the field of biotechnology, and more particularly to a biomarker, kit, and application for the diagnosis of pancreatic malignant tumors. The biomarker comprises aldehyde-ketone reductase 1B10 protein and carbohydrate antigen 19-9 protein. This biomarker is a secreted serum protein that can specifically distinguish PDAC patients from normal individuals, and from individuals with benign pancreatic diseases, exhibiting high specificity without significant non-specific elevation interference. Combined detection with CA199 can synergistically enhance diagnostic efficacy, significantly reducing the rate of missed diagnoses and misdiagnoses. Simultaneously, this biomarker can assess the postoperative tumor resection effect in PDAC patients, predict whether curative resection is achieved, and provide an effective target for postoperative prognostic monitoring.
Owner:SHENZHEN PEOPLES HOSPITAL

Nonconductive field guide for resection cavity, and systems and methods of using same

A method for treating tumor cells around a resection cavity comprises positioning a nonconductive material within a resection cavity that is adjacent to a target region. At least a first electrode and a second electrode are positioned relative to the tumor resection cavity so that electric fields between the at least one first electrode and the at least one second electrode travel through the target region. Tumor-treating electric fields are the generated between the at least one first electrode and the at least one second electrode.
Owner:NOVOCURE GMBH

Drug Eluting Shape Memory Foam

Tumor resection is commonly practiced to prevent the progression of cancer. However, there are post-surgery concerns including the formation of a void that can allow cancer cells to escape at the surgery site, which increases the risk of metastasis. To counter this challenge, an embodiment includes a polyurethane-based shape memory foam as a tissue void-filling device that can also release anti-cancer drugs. Such foams may activate at body temperature and become malleable. Such properties may enable the foam to be shaped to precisely seal the tissue void and then serve as a drug-eluting device. Based on the drug composition with poly vinyl alcohol (PVA), the drug release profile from the foam may be altered depending on the application.
Owner:TEXAS A&M UNIVERSITY

Tumor resection operation planning method and system based on 3D model and storage medium

The invention belongs to the technical field of medical image processing, and discloses a tumor resection operation planning method and system based on a 3D model, and a storage medium. The method comprises the following steps: obtaining a first medical image and a second medical image, and extracting all blood vessel branch structures in a target organ in each medical image, registering the first medical image and the second medical image based on a common branch structure, generating a third medical image, extracting a tumor area and a blood supply branch connected with the tumor, calculating the shortest distance from the center point of the tumor to the outer surface of the target organ, judging whether the shortest distance is smaller than a first preset value or not, if yes, generating a first surgical area, and if not, generating a second surgical area; and if not, generating a second surgical area, and planning a planned resection range and a surgical approach based on the surgical area. According to the technical scheme, the accuracy and the success rate of the operation can be improved.
Owner:SHAANXI CANCER HOSPITAL (SHAANXI INST OF CANCER PREVENTION & TREATMENT) (SHAANXI THIRD PEOPLES HOSPITAL)

Nonconductive Field Guide For Resection Cavity, And Systems And Methods Of Using Same

A method for treating tumor cells around a resection cavity comprises positioning a nonconductive material within a resection cavity that is adjacent to a target region. At least a first electrode and a second electrode are positioned relative to the tumor resection cavity so that electric fields between the at least one first electrode and the at least one second electrode travel through the target region. Tumor-treating electric fields are the generated between the at least one first electrode and the at least one second electrode.
Owner:NOVOCURE GMBH

Intelligent image recognition system and method in fluorescence state

The invention discloses an intelligent image recognition method in a fluorescence state, and relates to the technical field of medical equipment, and the method comprises the following steps: collecting a fluorescence image and a white light image at the same time point through 4K fluorescence endoscope camera equipment, and carrying out the image preprocessing, including illumination correction, fuzzy correction, filtering and denoising, and edge enhancement; based on a Mask RCNN algorithm, performing intelligent identification on a tumor boundary in the fluorescence image, and identifying the tumor boundary in the fluorescence image; performing spatial alignment on the fluorescent image and the white light image through an image registration technology; based on a GAN algorithm, fusing the identified tumor boundary with the white light image to generate a high-precision fused image; automatically marking a safe cutting edge in the white light image according to a preset safe cutting edge distance; and finally, displaying the marked white light image in real time to assist a doctor in tumor excision. According to the invention, the operation burden of a doctor in image switching is reduced, and the accuracy of an operation is improved.
Owner:HEFEI DVL ELECTRON CO LTD

Longitudinal and transverse-VI eyelid marginal tumor resection and surgical repair integrated device

ActiveCN119791949AEye surgeryOperating tablesSurgical incisionSurgical repair
The invention relates to the technical field of medical instruments, in particular to a longitudinal and transverse-VI eyelid margin tumor resection and surgical repair integrated device which comprises a rack, a position adjusting module, a transverse knife module, a longitudinal knife module, a knife control module, an eyelid base plate, a folding module and a needle guiding module. The transverse knife module and the longitudinal knife module are installed below the position adjusting module from back to front, the knife control module is arranged above the transverse knife module and the longitudinal knife module, the eyelid base plate is installed below the position adjusting module, and the involution module and the needle guiding module are both installed on the eyelid base plate. An inner thread hole and an outer thread hole are sequentially formed in the eyelid base plate from the middle to the left side and the right side; by optimizing a surgical incision and improving a suturing mode and executing the optimization and the improvement through an integrated device, the purposes of layered involution of meibomian tissues and skin tissues and improvement and stabilization of the surgical effect are achieved.
Owner:NING BO EYE HOSPITAL

Protease-activated contrast agents for in vivo imaging

Compounds useful as contrast agents in image-guided surgery are provided. The compounds comprise a latent cationic lysosomotropic fragment that is detectable upon cleavage by lysosomal proteases within treated tissues, particularly within tumors and other diseased tissues. Also provided are compositions comprising the compounds and methods for using the compounds, for example in dynamically monitoring protease activity in vivo during image-guided tumor resection surgery.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Drug eluting shape memory foam

The invention relates to drug eluting shape memory foams. Tumorectomy is typically performed to prevent the progression of cancer. However, there is postoperative concern, including the formation of voids that may allow cancer cells to escape at the surgical site, which increases the risk of metastasis. To combat this challenge, embodiments include a polyurethane-based shape memory foam as a tissue void filling device, which can also release an anti-cancer drug. Such foams can be activated at body temperature and become malleable. Such properties may enable the foam to be shaped to precisely seal tissue voids, and then act as a drug eluting device. Based on a pharmaceutical composition having polyvinyl alcohol (PVA), the characteristic of drug release from foam can be varied depending on application.
Owner:TEXAS A&M UNIVERSITY

Systems and methods for minimal residual disease analysis

Provided herein are methods and systems for cancer detection and monitoring. The methods may include minimal residual disease analysis. The methods may include using nucleic acids from a urine sample or a urine cell pellet sample. The methods may include assaying nucleic acids in urine to detect a set of biomarkers from the sample. The methods may include monitoring a subject after transurethral bladder tumor resection.
Owner:PREDICINE INC

Construction method and application of CMS prediction model

The invention relates to the technical field of medical data processing, and discloses a construction method and application of a CMS prediction model, and the method comprises the steps: obtaining a damage map of a CNS tumor patient group and a voxel value of each individual by using a preoperative MRI image and a tumor mask of the CNS tumor patient group with / without CMS after a child posterior fossal tumor resection operation; the method comprises the following steps of: selecting voxel value data and gender data, screening out significant variable data significantly related to CMS through a regression analysis method, verifying the correlation intensity of the voxel value data and the gender data to appearing / non-appearing CMS, and training to obtain a high-precision CMS prediction model by using the significant variable data of a target population related to the CMS and labels of appearing / non-appearing CMS on an MRI image. The method can assist in accurately evaluating whether a CMS risk occurs after a CNS tumor patient accepts a child posterior fossa tumor resection operation, and is beneficial for doctors and parents to prepare good emotional support and directional rehabilitation plans in advance.
Owner:BEIJING CHILDRENS HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Anti-tumor electrospinning stent and preparation method thereof

The invention belongs to the technical field of medical instruments, and particularly discloses an anti-tumor electrospinning stent and a preparation method thereof. The drug-loaded electrospinning stent is characterized by comprising a drug-loaded electrospinning stent main body and tumor cell-derived drug-loaded microparticles loaded on the surface of the drug-loaded electrospinning stent main body. The drug-loaded electrospinning stent main body comprises an amino polymer, a hydrophilic polymer and celecoxib which are prepared by using an electrospinning technology and have a mass ratio of (2-10): (2-13): 1, and the drug-loaded electrospinning stent main body has high specific surface area and high porosity; the loading capacity of the tumor cell source doxorubicin-loaded microparticles on the anti-tumor electrospinning bracket is 0.6 mu g / mg to 6.1 mu g / mg. The drug is directly delivered to a tumor resection cavity in an in-situ implantation mode, and long-acting drug retention, continuous drug release and complete degradation of a stent material are achieved. The tumor immune microenvironment is remodeled while residual tumor cells are effectively killed, and recurrence and metastasis of tumors are inhibited.
Owner:HUAZHONG UNIV OF SCI & TECH

Non-small cell lung cancer tissue discrimination model based on differential metabolite combination as well as construction method and application of non-small cell lung cancer tissue discrimination model

The invention belongs to the technical field of biomedicine, and particularly relates to a non-small cell lung cancer tissue discrimination model based on differential metabolite combination as well as a construction method and application of the non-small cell lung cancer tissue discrimination model. The differential metabolite combination is composed of lactic acid, phosphoethanolamine, decenoyl carnitine and symmetric dimethylarginine or composed of xanthine, phosphoethanolamine, N-acetyl aspartic acid, decenoyl carnitine and symmetric dimethylarginine, and the determination model establishment method comprises the following steps: collecting and treating a lung cancer tissue sample, carrying out UPLC-HRMS detection, carrying out compound identification, and carrying out quantitative determination. Differential metabolites are screened, key differential metabolites are selected through an LASSO method, the performance of all models based on the key differential metabolites is tested, and the selected optimal model is a logistic regression model. The logistic regression discrimination model based on four or five differential metabolites can effectively distinguish non-small cell lung cancer tumor tissues and normal tissues, and the accuracy, the sensitivity, the specificity, the F1 fraction and the AUC are all greater than 0.8. The model has a small quantity of metabolites, and shows the potential of assisting in clinical detection of non-small cell lung cancer tissues and the potential of assisting surgeons in determining a tumor excision range.
Owner:OCEAN UNIV OF CHINA